Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-063553
Filing Date
2025-05-05
Accepted
2025-05-05 16:15:17
Documents
51
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rlay-20250331.htm   iXBRL 10-Q 2089973
2 EX-31.1 rlay-ex31_1.htm EX-31.1 18588
3 EX-31.2 rlay-ex31_2.htm EX-31.2 18407
4 EX-32.1 rlay-ex32_1.htm EX-32.1 16953
  Complete submission text file 0000950170-25-063553.txt   7564680

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rlay-20250331.xsd EX-101.SCH 1014929
53 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20250331_htm.xml XML 1313762
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39385 | Film No.: 25913136
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)